Insider · CIK 0001046351

COOPER GLENN L MD

Reports to the SEC for 4 companies · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001046351

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-05-23	RGENREPLIGEN CORPM Exercise/Conversion	Director	MExercise/Conversion	+24K sh	$5.00	+$120K	64,709
2019-05-23	RGENREPLIGEN CORPS Sale	Director	SSale	−4,734 sh	$66.91	−$317K	35,975
2019-05-23	RGENREPLIGEN CORPS Sale	Director	SSale	−266 sh	$67.53	−$18K	35,709
2019-05-23	RGENREPLIGEN CORP · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−24K sh	—	—	0
2019-05-23	RGENREPLIGEN CORPS Sale	Director	SSale	−266 sh	$67.53	−$18K	59,709
2019-05-23	RGENREPLIGEN CORPS Sale	Director	SSale	−4,734 sh	$66.91	−$317K	59,975
2019-05-15	RGENREPLIGEN CORP · Stock Option (Right to Buy)A Award	Director	AAward	+2,109 sh	—	—	2,109
2019-05-15	RGENREPLIGEN CORPA Award	Director	AAward	+923 sh	—	—	40,709
2018-05-16	RGENREPLIGEN CORP · Stock Option (Right to Buy)A Award	Director	AAward	+3,304 sh	—	—	3,304
2018-05-16	RGENREPLIGEN CORPA Award	Director	AAward	+1,486 sh	—	—	39,786
2017-05-18	RGENREPLIGEN CORPA Award	Director	AAward	+1,206 sh	—	—	38,300
2017-05-18	RGENREPLIGEN CORP · Stock Option (Right to Buy)A Award	Director	AAward	+2,434 sh	—	—	2,434
2016-05-11	RGENREPLIGEN CORP · Stock Option (Right to Buy)A Award	Director	AAward	+3,366 sh	—	—	3,366
2016-05-11	RGENREPLIGEN CORPA Award	Director	AAward	+1,763 sh	—	—	37,094
2015-11-09	RGENREPLIGEN CORPA Award	Director	AAward	+1,000 sh	$26.56	+$26.6K	35,331
2015-05-21	RGENREPLIGEN CORPA Award	Director	AAward	+1,019 sh	—	—	34,331
2015-05-21	RGENREPLIGEN CORP · Stock Option (Right to Buy)A Award	Director	AAward	+1,992 sh	—	—	1,992
2013-05-09	RGENREPLIGEN CORPA Award	Director	AAward	+5,342 sh	—	—	31,380
2012-11-30	FBIOFortress Biotech, Inc.P Purchase	Director, See Remarks	PPurchase	+3,811 sh	$4.02	+$15.3K	43,811
2012-09-21	RGENREPLIGEN CORPP Purchase	Director	PPurchase	+3,000 sh	$6.09	+$18.3K	24,038
2012-09-21	RGENREPLIGEN CORPP Purchase	Director	PPurchase	+2,000 sh	$6.08	+$12.2K	26,038
2012-09-21	RGENREPLIGEN CORPP Purchase	Director	PPurchase	+5,000 sh	$6.09	+$30.4K	21,038
2012-06-22	FBIOFortress Biotech, Inc.P Purchase	Director, See Remarks	PPurchase	+10K sh	$5.30	+$53K	40,000
2012-05-24	RGENREPLIGEN CORPA Award	Director	AAward	+11K sh	—	—	16,038
2012-02-10	FBIOFortress Biotech, Inc. · Options to purchase Common StockA Award	Director, See Remarks	AAward	+45K sh	—	—	45,000
2011-12-15	RGENREPLIGEN CORP · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	59,000
2010-09-16	RGENREPLIGEN CORP · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	44,000
2009-11-09	RGENREPLIGEN CORPP Purchase	Director	PPurchase	+5,000 sh	$4.98	+$24.9K	5,000
2009-08-24	RGENREPLIGEN CORP · Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2009-02-24	Endo Pharmaceuticals Solutions Inc.U Disposition from Tender	Director, CEO	UDisposition from Tender	−280K sh	—	—	0
2009-02-23	Endo Pharmaceuticals Solutions Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+280K sh	—	—	279,898
2009-02-23	Endo Pharmaceuticals Solutions Inc.U Disposition from Tender	Director, CEO	UDisposition from Tender	−467K sh	—	—	0
2009-02-23	Endo Pharmaceuticals Solutions Inc.Performance RightsM Exercise/Conversion	Director, CEO	MExercise/Conversion	−280K sh	—	—	52,412
2008-12-04	Endo Pharmaceuticals Solutions Inc.Stock Option (Right to Buy)A Award	Director, CEO	AAward	+800K sh	—	—	800,000
2008-12-04	Endo Pharmaceuticals Solutions Inc.Stock Option (Right to Buy)A Award	Director, CEO	AAward	+70K sh	—	—	70,000
2008-12-04	Endo Pharmaceuticals Solutions Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO	DDisposition to Issuer	−70K sh	—	—	0
2008-12-04	Endo Pharmaceuticals Solutions Inc.Stock Option (Right to Buy)A Award	Director, CEO	AAward	+360K sh	—	—	360,000
2008-12-04	Endo Pharmaceuticals Solutions Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO	DDisposition to Issuer	−360K sh	—	—	0
2008-12-04	Endo Pharmaceuticals Solutions Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO	DDisposition to Issuer	−800K sh	—	—	0
2008-12-04	Endo Pharmaceuticals Solutions Inc.Stock Option (Right to Buy)A Award	Director, CEO	AAward	+60K sh	—	—	60,000
2008-12-04	Endo Pharmaceuticals Solutions Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO	DDisposition to Issuer	−60K sh	—	—	0
2008-09-25	Endo Pharmaceuticals Solutions Inc.A Award	Director, CEO	AAward	+158K sh	—	—	467,091
2008-09-25	Endo Pharmaceuticals Solutions Inc.Performance RightsA Award	Director, CEO	AAward	0 sh	—	—	0
2007-10-30	Endo Pharmaceuticals Solutions Inc.Performance RightsA Award	Director, CEO	AAward	0 sh	—	—	0
2007-10-30	Endo Pharmaceuticals Solutions Inc.A Award	Director, CEO	AAward	+42K sh	—	—	308,900
2006-01-09	Endo Pharmaceuticals Solutions Inc.P Purchase	Director, CEO	PPurchase	+10K sh	$5.85	+$58.5K	195,000
2005-02-15	Endo Pharmaceuticals Solutions Inc.P Purchase	Director, CEO	PPurchase	+10K sh	$4.05	+$40.5K	185,000
1999-07-13	GENTA INC DE/Non-Employee Directors' 1998 Stock Option Plan OptionsA Award	Director	AAward	−50K sh	—	—	387,500

Recent filings

Accepted (ET)
Jun 194/A
COOPER GLENN L MD0000899243-19-017486
SEC(opens sec.gov)
May 284
COOPER GLENN L MD0000899243-19-014849
SEC(opens sec.gov)
May 174
COOPER GLENN L MD0000899243-19-013992
SEC(opens sec.gov)
May 174
COOPER GLENN L MD0001140361-18-024447
SEC(opens sec.gov)
May 224
REPLIGEN CORP0001140361-17-021757
SEC(opens sec.gov)
May 134
REPLIGEN CORP0001140361-16-065155
SEC(opens sec.gov)
Nov 124
REPLIGEN CORP0001140361-15-040640
SEC(opens sec.gov)
May 264
REPLIGEN CORP0001140361-15-021750
SEC(opens sec.gov)
May 164
COOPER GLENN L MD0001140361-13-021270
SEC(opens sec.gov)
Dec 34
COOPER GLENN L MD0001181431-12-061833
SEC(opens sec.gov)
Sep 244
COOPER GLENN L MD0001140361-12-041306
SEC(opens sec.gov)

Companies

Address

INDEVUS PHARMACEUTICALS, INC. 33 HAYDEN AVENUE

LEXINGTON, MA, 02421